ArticleMedicine international
Cold agglutinin syndrome as a precursor for the diagnosis of low‑grade lymphoma: A case report.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rituximab combined with lenalidomide for the treatment of marginal zone lymphoma with IgM kappa positivity and cold agglutinin syndrome: a case report.Frontiers in immunology · 2026Article
- Complement inhibition by sutimlimab in cold agglutinin disease promotes red blood cell agglutination and may lead to circulatory complications, eryptosis and hemolysis.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cold agglutinin syndrome is a form of acquired hemolytic anemia that typically arises from underlying conditions, such as infections, autoimmune disorders or lymphoid malignancies. The majority of patients remain asymptomatic and are diagnosed with anemia through routine complete blood count (CBC) testing. The present study describes the case of a male patient in his 50s who sought a second opinion at the authors' clinic due to newly detected anemia. A peripheral blood smear revealed red blood cell (RBC) agglutination, and testing confirmed the presence of cold agglutinin antibodies. Thoracoabdominal computed tomography identified a mass in the right kidney, leading to a partial nephrectomy. A pathological examination of the mass confirmed a diagnosis of renal cell carcinoma. At that time, no secondary cause for the cold agglutinin syndrome was identified. At 2 years following his initial admission, the patient presented with bilaterally enlarging masses in the groin. A biopsy was performed, which revealed low-grade B-cell lymphoma. Following R-CHOP treatment, the RBC agglutination was resolved, and the CBC returned to normal ranges. On the whole, the present study demonstrates that cold agglutinin syndrome may serve as an early indicator of lymphoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.